Go Pro
→ SPCX Warning - and Worst News for Stocks in 50 Years (From TradeSmith) (Ad)tc pixel Free APT Stock Alerts

Alpha Pro Tech (APT) Competitors

Alpha Pro Tech logo
$5.12 +0.09 (+1.79%)
Closing price 07/14/2026 04:00 PM Eastern
Extended Trading
$5.09 -0.03 (-0.59%)
As of 07/14/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

APT vs. LUCD, RXST, FOCL, PDEX, and KRMD

Should you buy Alpha Pro Tech stock or one of its competitors? MarketBeat compares Alpha Pro Tech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alpha Pro Tech include Lucid Diagnostics (LUCD), RxSight (RXST), FocalTherics (FOCL), Pro-Dex (PDEX), and KORU Medical Systems (KRMD). These companies are all part of the "medical equipment" industry.

How does Alpha Pro Tech compare to Lucid Diagnostics?

Lucid Diagnostics (NASDAQ:LUCD) and Alpha Pro Tech (NYSE:APT) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

74.0% of Lucid Diagnostics shares are owned by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are owned by institutional investors. 6.9% of Lucid Diagnostics shares are owned by company insiders. Comparatively, 16.2% of Alpha Pro Tech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Alpha Pro Tech has higher revenue and earnings than Lucid Diagnostics. Lucid Diagnostics is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lucid Diagnostics$4.71M43.11-$58.01M-$0.47N/A
Alpha Pro Tech$59.91M0.87$4.19M$0.3514.63

Alpha Pro Tech has a net margin of 6.99% compared to Lucid Diagnostics' net margin of -876.72%. Alpha Pro Tech's return on equity of 6.70% beat Lucid Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Lucid Diagnostics-876.72% N/A -116.26%
Alpha Pro Tech 6.99%6.70%5.76%

Lucid Diagnostics has a beta of 1.07, indicating that its stock price is 7% more volatile than the broader market. Comparatively, Alpha Pro Tech has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market.

In the previous week, Lucid Diagnostics had 1 more articles in the media than Alpha Pro Tech. MarketBeat recorded 1 mentions for Lucid Diagnostics and 0 mentions for Alpha Pro Tech. Lucid Diagnostics' average media sentiment score of 1.87 beat Alpha Pro Tech's score of 0.00 indicating that Lucid Diagnostics is being referred to more favorably in the media.

Company Overall Sentiment
Lucid Diagnostics Very Positive
Alpha Pro Tech Neutral

Lucid Diagnostics currently has a consensus price target of $4.19, suggesting a potential upside of 318.75%. Given Lucid Diagnostics' stronger consensus rating and higher probable upside, equities research analysts clearly believe Lucid Diagnostics is more favorable than Alpha Pro Tech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lucid Diagnostics
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Alpha Pro Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Lucid Diagnostics and Alpha Pro Tech tied by winning 8 of the 16 factors compared between the two stocks.

How does Alpha Pro Tech compare to RxSight?

RxSight (NASDAQ:RXST) and Alpha Pro Tech (NYSE:APT) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, media sentiment, risk, valuation, profitability, analyst recommendations and institutional ownership.

Alpha Pro Tech has a net margin of 6.99% compared to RxSight's net margin of -36.58%. Alpha Pro Tech's return on equity of 6.70% beat RxSight's return on equity.

Company Net Margins Return on Equity Return on Assets
RxSight-36.58% -17.01% -15.12%
Alpha Pro Tech 6.99%6.70%5.76%

RxSight presently has a consensus price target of $8.89, suggesting a potential upside of 80.67%. Given RxSight's stronger consensus rating and higher possible upside, equities analysts clearly believe RxSight is more favorable than Alpha Pro Tech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RxSight
3 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.92
Alpha Pro Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

RxSight has a beta of 1.15, indicating that its share price is 15% more volatile than the broader market. Comparatively, Alpha Pro Tech has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market.

In the previous week, RxSight had 8 more articles in the media than Alpha Pro Tech. MarketBeat recorded 8 mentions for RxSight and 0 mentions for Alpha Pro Tech. RxSight's average media sentiment score of 0.35 beat Alpha Pro Tech's score of 0.00 indicating that RxSight is being referred to more favorably in the media.

Company Overall Sentiment
RxSight Neutral
Alpha Pro Tech Neutral

78.8% of RxSight shares are owned by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are owned by institutional investors. 10.1% of RxSight shares are owned by insiders. Comparatively, 16.2% of Alpha Pro Tech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Alpha Pro Tech has lower revenue, but higher earnings than RxSight. RxSight is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RxSight$134.48M1.51-$38.94M-$1.13N/A
Alpha Pro Tech$59.91M0.87$4.19M$0.3514.63

Summary

RxSight beats Alpha Pro Tech on 9 of the 16 factors compared between the two stocks.

How does Alpha Pro Tech compare to FocalTherics?

FocalTherics (NASDAQ:FOCL) and Alpha Pro Tech (NYSE:APT) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

FocalTherics has a beta of -0.04, suggesting that its share price is 104% less volatile than the broader market. Comparatively, Alpha Pro Tech has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market.

Alpha Pro Tech has a net margin of 6.99% compared to FocalTherics' net margin of -41.47%. Alpha Pro Tech's return on equity of 6.70% beat FocalTherics' return on equity.

Company Net Margins Return on Equity Return on Assets
FocalTherics-41.47% -137.61% -40.62%
Alpha Pro Tech 6.99%6.70%5.76%

62.7% of FocalTherics shares are held by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are held by institutional investors. 10.1% of FocalTherics shares are held by insiders. Comparatively, 16.2% of Alpha Pro Tech shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, FocalTherics had 1 more articles in the media than Alpha Pro Tech. MarketBeat recorded 1 mentions for FocalTherics and 0 mentions for Alpha Pro Tech. FocalTherics' average media sentiment score of 1.89 beat Alpha Pro Tech's score of 0.00 indicating that FocalTherics is being referred to more favorably in the media.

Company Overall Sentiment
FocalTherics Very Positive
Alpha Pro Tech Neutral

Alpha Pro Tech has lower revenue, but higher earnings than FocalTherics. FocalTherics is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FocalTherics$70.53M2.87-$29.25M-$0.81N/A
Alpha Pro Tech$59.91M0.87$4.19M$0.3514.63

FocalTherics currently has a consensus price target of $6.00, suggesting a potential upside of 10.91%. Given FocalTherics' stronger consensus rating and higher probable upside, equities analysts plainly believe FocalTherics is more favorable than Alpha Pro Tech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FocalTherics
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Alpha Pro Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

FocalTherics and Alpha Pro Tech tied by winning 8 of the 16 factors compared between the two stocks.

How does Alpha Pro Tech compare to Pro-Dex?

Alpha Pro Tech (NYSE:APT) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation and institutional ownership.

Alpha Pro Tech has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.01, indicating that its share price is 99% less volatile than the broader market.

Pro-Dex has a net margin of 16.08% compared to Alpha Pro Tech's net margin of 6.99%. Pro-Dex's return on equity of 22.78% beat Alpha Pro Tech's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Pro Tech6.99% 6.70% 5.76%
Pro-Dex 16.08%22.78%14.30%

Pro-Dex has a consensus price target of $70.00, suggesting a potential upside of 20.15%. Given Pro-Dex's stronger consensus rating and higher probable upside, analysts clearly believe Pro-Dex is more favorable than Alpha Pro Tech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Pro Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Pro-Dex
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Pro-Dex had 5 more articles in the media than Alpha Pro Tech. MarketBeat recorded 5 mentions for Pro-Dex and 0 mentions for Alpha Pro Tech. Pro-Dex's average media sentiment score of 1.46 beat Alpha Pro Tech's score of 0.00 indicating that Pro-Dex is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Pro Tech Neutral
Pro-Dex Positive

Pro-Dex has higher revenue and earnings than Alpha Pro Tech. Alpha Pro Tech is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Pro Tech$59.91M0.87$4.19M$0.3514.63
Pro-Dex$66.59M2.79$8.98M$3.6216.09

22.7% of Alpha Pro Tech shares are held by institutional investors. Comparatively, 15.3% of Pro-Dex shares are held by institutional investors. 16.2% of Alpha Pro Tech shares are held by company insiders. Comparatively, 45.9% of Pro-Dex shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Pro-Dex beats Alpha Pro Tech on 14 of the 16 factors compared between the two stocks.

How does Alpha Pro Tech compare to KORU Medical Systems?

Alpha Pro Tech (NYSE:APT) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations, media sentiment and institutional ownership.

Alpha Pro Tech has a net margin of 6.99% compared to KORU Medical Systems' net margin of -5.27%. Alpha Pro Tech's return on equity of 6.70% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Pro Tech6.99% 6.70% 5.76%
KORU Medical Systems -5.27%-13.61%-8.33%

22.7% of Alpha Pro Tech shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 16.2% of Alpha Pro Tech shares are owned by insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Alpha Pro Tech has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.41, suggesting that its stock price is 59% less volatile than the broader market.

In the previous week, KORU Medical Systems had 3 more articles in the media than Alpha Pro Tech. MarketBeat recorded 3 mentions for KORU Medical Systems and 0 mentions for Alpha Pro Tech. KORU Medical Systems' average media sentiment score of 0.62 beat Alpha Pro Tech's score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Pro Tech Neutral
KORU Medical Systems Positive

Alpha Pro Tech has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Pro Tech$59.91M0.87$4.19M$0.3514.63
KORU Medical Systems$41.13M4.63-$2.64M-$0.05N/A

KORU Medical Systems has a consensus target price of $7.25, suggesting a potential upside of 74.70%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than Alpha Pro Tech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Pro Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

Summary

Alpha Pro Tech and KORU Medical Systems tied by winning 8 of the 16 factors compared between the two stocks.

Get Alpha Pro Tech News Delivered to You Automatically

Sign up to receive the latest news and ratings for APT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APT vs. The Competition

Export
MetricAlpha Pro TechSurgical appliances & supplies IndustryIndustrials SectorNYSE Exchange
Market Cap$52.31M$23.85M$9.40B$23.45B
Dividend YieldN/AN/A3.54%4.02%
P/E Ratio13.8413.8426.7531.16
Price / Sales0.871.641,939.9019.75
Price / Cash12.8012.8027.3724.88
Price / Book0.971.554.434.78
Net Income$4.19M-$3.92M$791.21M$1.07B
7 Day Performance6.00%2.65%-0.02%0.78%
1 Month Performance-3.76%-4.81%-0.54%0.21%
1 Year Performance8.02%-25.43%15.37%18.52%

Alpha Pro Tech Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APT
Alpha Pro Tech
N/A$5.12
+1.8%		N/A+6.4%$52.31M$59.91M13.84120
LUCD
Lucid Diagnostics
4.2733 of 5 stars		$1.01
+1.5%		$4.19
+316.7%		-14.5%$205.10M$5.13MN/A70
RXST
RxSight
2.6476 of 5 stars		$4.92
-3.2%		$8.89
+80.9%		-36.4%$203.61M$134.48MN/A220
FOCL
FocalTherics
2.2873 of 5 stars		$5.40
-1.5%		$6.00
+11.1%		N/A$202.39M$70.53MN/A230
PDEX
Pro-Dex
3.853 of 5 stars		$62.95
+1.5%		$70.00
+11.2%		+26.0%$200.80M$66.59M17.39140

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:APT) was last updated on 7/15/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel